a maker of biologic therapeutics for oncology and inflammatory diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CHRS has been loosely correlated with PRME. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CHRS jumps, then PRME could also see price increases.
Ticker / NAME | Correlation To CHRS | 1D Price Change % | ||
---|---|---|---|---|
CHRS | 100% | -0.78% | ||
PRME - CHRS | 44% Loosely correlated | -9.22% | ||
SWTX - CHRS | 40% Loosely correlated | +5.30% | ||
QSI - CHRS | 40% Loosely correlated | -1.52% | ||
MGTX - CHRS | 40% Loosely correlated | -5.68% | ||
DNLI - CHRS | 39% Loosely correlated | -3.98% | ||
More |
Ticker / NAME | Correlation To CHRS | 1D Price Change % |
---|---|---|
CHRS | 100% | -0.78% |
therapeutics theme (53 stocks) | 47% Loosely correlated | -2.40% |
drugs theme (254 stocks) | 46% Loosely correlated | -1.67% |
cancer theme (82 stocks) | 46% Loosely correlated | -2.35% |
biotechnology theme (238 stocks) | 29% Poorly correlated | -1.76% |
biological theme (25 stocks) | 29% Poorly correlated | -1.51% |
More |